SC Order For Free Covid-19 Test May Hinder Fight
Apr 9, 2020 | Pratirodh Bureau
A doctor wearing protective gear prepares to take a swab from a girl to test for the coronavirus disease at a residential area in Ahmedabad on April 8, 2020
A decision by the Supreme Court to make testing for coronavirus free places an unfair financial burden on medical firms and could see a reduction in testing, already among the world’s lowest, said business leaders and health experts.
The concern is that private medical firms, like many businesses in India, are struggling financially, and could go under if they tested for free without financial assistance.
Kiran Mazumdar Shaw, executive chairperson of Biocon Limited, one of India’s biggest biotech firms, said private institutions could not be expected to operate on credit.
“Humanitarian in intent but impractical to implement – I fear testing will plummet,” Shaw said on twitter on Thursday about the court judgement.
“These are small businesses, they’re providing testing at cost and not profiteering. How will they pay their employees?”
The top court, responding to a public interest petition, said on Wednesday that private medical institutions should be playing a philanthropic role at a time of national crisis and it would not allow a situation where India’s poor could not afford a test for the virus that is quickly spreading through the country.
It said the issue of reimbursing these laboratories for running the hundreds of thousands of tests for novel coronavirus that the world’s second most populous country urgently needs would be considered later on.
India has 5,734 cases of coronavirus and 166 deaths from COVID-19, the respiratory disease caused by the virus, according to the Ministry of Health and Family Welfare, reflecting a jump of 460 cases over Wednesday.
The numbers are small compared to the United States, Italy and Spain and one of the reasons is that the country is testing a narrow range of the population, doctors say.
These include people who have travelled overseas, people in contact with them and are showing symptoms, health workers with symptoms, hospitalised patients with respiratory problems and those who came in contact with a confirmed patient.
On Wednesday, 13,143 samples were tested nationwide, the government-run Indian Council of Medical Research said, well behind the 20,000 people South Korea has been testing each day from its far smaller population.